Although opioid substitution therapy (OST) immediately after
prison release reduces mortality, the cost-effectiveness of treatment has not
been examined. Therefore, we undertook a cost-effectiveness analysis of OST
treatment upon prison release and the prevention of death in the first 6 months
post-release.
Design: Population-based, retrospective data linkage study using
records of OST entrants (1985-2010), charges and court appearances (1993-2011),
prison episodes (2000-11) and death notifications (1985-2011).
Participants: A cohort of 16 073 people with a history of opioid
dependence released from prison for the first time between 1 January 2000 and
30 June 2011.
Intervention: OST treatment compared to no OST treatment at prison release.
Measurements: Mortality and costs (treatment, criminal justice
system-court, penalties, prison-and the social costs of crime) were evaluated
at 6 months post-release. Analyses included propensity score matching,
bootstrapping and regression.
A total of 13 468 individuals were matched (6734 in each
group). Twenty (0.3%) people released onto OST died, compared with 46 people
(0.7%) not released onto OST. The final average costs were lower for the group
that received OST post-release ($7206 versus $14 356). The incremental
cost-effectiveness ratio showed that OST post-release was dominant, incurring
lower costs and saving more lives. The probability that OST post-release is
cost-effective per life-year saved is 96.7% at a willingness to pay of $500.
Opioid substitution treatment (compared with no such
treatment), given on release from prison to people with a history of opioid
dependence, is cost-effective in reducing mortality in the first 6 months of
release.
Purchase full article at: http://goo.gl/BJ5B0g
By: Gisev N1, Shanahan M1, Weatherburn DJ2, Mattick RP1, Larney S1,3, Burns L1, Degenhardt L1,4.
- 1National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia.
- 2New South Wales Bureau of Crime Statistics and Research (BOCSAR), Sydney, New South Wales, Australia.
- 3Alpert Medical School, Brown University, Providence, Rhode Island, USA.
- 4School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment